Healthcare stocks in China

Intrinsic value and value investing analysis for healthcare stocks in China.

21 companies

Companies

• ZLAB - Zai Lab Limited ADR: slightly overvalued, -6% margin of safety
• AAPG - Ascentage Pharma Group International ADR: overvalued, -5960% margin of safety
• AHG - Akso Health Group ADR: overvalued, -495% margin of safety
• ANL - Adlai Nortye Group Ltd ADR: not valued
• ZJYL - Jin Medical International Ltd: overvalued, -63% margin of safety
• SY - So-Young International Inc ADR: overvalued, -136% margin of safety
• ADAG - Adagene Inc ADR: overvalued, -86% margin of safety
• BGM - BGM Group Ltd: overvalued, -467% margin of safety
• BNR - Burning Rock Biotech Ltd ADR: overvalued, -48% margin of safety
• ZYBT - Zhengye Biotechnology Holding Ltd: overvalued, -88% margin of safety
• CPHI - China Pharma Holdings Inc: not valued
• ITOC - iTonic Holdings Ltd: overvalued, -510% margin of safety
• YI - 111 Inc ADR: undervalued, +26% margin of safety
• POM - Pomdoctor Ltd: no published value
• CCM - Concord Medical Services ADR: not valued
• UPC - Universe Pharmaceuticals INC: no reliable verdict
• BDMD - Baird Medical Investment Holdings Limited: no reliable verdict
• ZCMD - Zhongchao Inc: undervalued, +71% margin of safety
• WOK - Work Medical Technology Group Ltd: undervalued, +47% margin of safety
• RDGT - Ridgetech Inc: no reliable verdict
• SXTC - China SXT Pharmaceuticals Inc: no reliable verdict